Nu Skin – NUS – Projects 2013 to be another record year

NYSE: NUS) provided its 2013 financial guidance in advance of its annual investor day. The company projects annual revenue of $2.25 to $2.30 billion, a 7 to 9 percent increase, or 8 to 10 percent on a constant currency basis. Earnings per share are estimated to be $3.70 to $3.85, an increase of 10 to 15 percent over 2012.

“As we conclude another successful year, we continue to generate healthy momentum and are projecting 2013 to be another record-breaking year for Nu Skin,” said Truman Hunt, president and chief executive officer. “We anticipate strong growth in our sales leaders and consumer base, healthy trends in all of our regions, and a record launch of our new ageLOC weight management system in 2013.  Our management team looks forward to sharing more details of our 2013 growth strategy, as well as our long-term plan for achieving our $4.00 per share target, at our annual investor day meeting today.”

About Nu Skin Enterprises, Inc. – NUS

Nu Skin Enterprises, Inc. (NUS) demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. NUS’s scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. NUS’s anti-aging products feature the new ageLOC^® suite of products including the ageLOC^® R² nutritional supplement, ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the ageLOC^® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and has more than 900,000 active distributors and preferred customers.

NUS is a global direct selling company with operations in 52 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively. The Company operates through a direct selling model with independent distributors in all of its markets except Mainland China. As of December 31, 2011, the Company had more than 850,000 distributors. The Company has two primary product categories, each operating under its own brand. It markets its personal care products under the Nu Skin brand and its nutritional supplements under the Pharmanex brand. During the year ended December 31, 2011, approximately 88% of its revenues came from its markets outside of the United States. On December 13, 2011, the Company acquired LifeGen Technologies, LLC (LifeGen).

More Posts by this author

• Sina Shares Slump on Outlook (SINA)
• Gold Prices End Marginally Higher, Posts Weekly Losses
• Market Update After Hours November 16
• Stocks End Higher
• Gold Prices Edge Higher; Silver Prices Fall
• Stocks Marginally Higher in Late Trading
• Stocks Bounce Back in Mid-Day Trading

Post Written By: Ed Liston Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.